We also suggested that EBV membrane proteins LMP1 and LMP2B, and EBV nuclear antigen EBNA1 are potential drug targets, because they not only participate in reactivation from the latent phase to the lytic phase, but also in the defensive mechanisms of virion production at both infection stages, as shown in Figs 5 and 6, respectively. The gene discussed is PDLIM7; the disease is infection.